Real-Time PCR qPCR Market

Real-Time PCR qPCR Market Outlook (2024 to 2034)

Worldwide demand for real-time PCR qPCR systems is estimated at a market value of US$ 4.19 billion in 2024. The global real-time PCR qPCR market is forecasted to expand at 8.3% CAGR and reach US$ 9.31 billion by the end of 2034.

Polymerase enzymes, primers, and many heat cycles are used in the polymer chain reaction (PCR), which produces an infinite number of copies of DNA from a single strand. Because PCR diagnoses are carried out in automated thermal cyclers, there is less chance of cross-contamination. In research, pharmaceutical, and biotech businesses, dPCR (digital polymerase chain reaction) and qPCR (quantitative polymerase chain reaction) are frequently employed in diagnostic procedures with a wide range of applications.

Real-time PCR qPCR systems enable early and precise illness detection, facilitating quick and targeted patient care. Additionally, because PCR techniques are more specific and have become a crucial component of laboratory diagnosis, they have supplanted traditional infectious disease detection methods like immunoassays, which have facilitated market expansion.

Due to the growing need for quick and accurate diagnostic instruments, real-time PCR qPCR is becoming an essential part of molecular diagnostics. It is essential in fields including genetic testing, pathogen detection, infectious disease testing, and cancer due to its exceptional sensitivity and specificity in detecting and quantifying nucleic acids.

Key Market Growth Drivers

• Real-time PCR qPCR market growth is being driven by increasing its use for SNP genotyping, mutation detection, and gene expression analysis in many scientific domains such as transcriptomics, microbiology, and genomics.
• Real-time PCR technology is constantly being improved to increase its speed, sensitivity, and accuracy. As a result, it is becoming an essential tool in molecular diagnostics for the detection and quantification of nucleic acids.
• Need for quick and precise diagnostic techniques, such as qPCR for pathogen identification and monitoring, is being driven by the rising prevalence of infectious illnesses such as epidemics and pandemics, throughout the world.
• Continuous advancements in qPCR equipment, reagents, and software to improve test efficiency, multiplexing potential, and user-friendliness are driving usage in various applications.
• Development of portable and user-friendly qPCR systems for point-of-care applications is driven by the move towards decentralized healthcare and the necessity for quick diagnostic testing, and this development is increasing accessibility and contributing to real-time PCR qPCR market size.

Report Attribute	Detail
Real-Time PCR qPCR Market Size (2024E)	US$ 4.19 Billion
Forecasted Market Value (2034F)	US$ 9.31 Billion
Global Market Growth Rate (2024 to 2034)	8.3% CAGR
North America Market Share (2024E)	38%
East Asia Market Value (2024E)	US$ 637 Million
Sales of Reagents and Assays (2034F)	US$ 4.17 Billion
Revenue from Use in Research (2034F)	US$ 5.33 Billion
Revenue from Use in Academic and Research Institutes (2034F)	US$ 2.36 Billion
Key Companies Profiled	Analytik Jena AG; Lumex Instruments; Agilent Technologies Inc.; Takara Bio Inc.; Bio-Rad Laboratories Inc.; Medtronic Plc; Abbott; Thermo Fisher Scientific, Inc.; Fluidigm Corporation; Cyberomic, Inc.; GE Healthcare.

What are the Benefits of Real-Time PCR qPCR in Genomics and Transcriptomics Research?

“Accurate Quantification of Gene Expression Levels and High Nucleic Acid Detection Sensitivity”

Accuracy and adaptability of real-time PCR qPCR are making them an essential tool in various research domains. Researchers in genomics examine regulatory systems driving biological activities measure mRNA levels and evaluate patterns of gene expression through qPCR. In transcriptomics, real-time PCR qPCR systems are used to profile changes in gene expression in response to stimuli or disease states, offering insights into the processes underlying diseases and possible targets for treatment.

qPCR makes SNP genotyping and mutation detection easier, enabling researchers to find genetic variants linked to specific illnesses or desirable qualities. Scientists rely on real-time PCR qPCR for precise and effective nucleic acid analysis, which is driving market expansion as it is widely used in transcriptomics, microbiology, and genomics research, advancing both fundamental and applied sciences.

Which Key Restraint is Faced by Real-Time PCR qPCR System Suppliers?

“High Initial Cost of Real-Time PCR qPCR Systems”

For smaller labs, research organizations, or hospitals that have low budgets, the expensive equipment and operational expenses of real-time PCR qPCR apparatus provide a major obstacle to adoption. The initial cost of qPCR equipment purchases, in addition to continuing costs for reagents, maintenance, and software upgrades, put a burden on finances and discourage investment in them.

Cost of purchase exceeds the anticipated benefits of qPCR technology for smaller businesses or research groups with limited funding, forcing them to turn to alternative approaches or the outsourcing of testing services. To overcome these financial obstacles, it is necessary to employ strategies such as cooperative collaborations, leasing programs, or group purchase agreements to pool resources and lower costs.

Country-wise Insights

The North American region is poised to lead with 38% of the global real-time PCR qPCR market share in 2024, due to the increasing utilization in academic & research institutes. Demand for real-time PCR qPCR systems in East Asia is projected to increase at 8.8% CAGR throughout the projection period (2024 to 2034).

Why are Sales of Real-Time PCR qPCR Systems High in the United States?

“Increasing Use of Real-Time PCR qPCR in Biotechnology & Research Labs”

Attribute	United States
Market Value (2024E)	US$ 1.35 Billion
Growth Rate (2024 to 2034)	8.2% CAGR
Projected Value (2034F)	US$ 2.96 Billion

The United States is poised to account for 84.7% market share in the North American region in 2024. In the United States, sales of real-time PCR qPCR products are rising due to the constant need for these tools in academic & research institutions, research labs, and biotechnological companies, and all of which have strong research ecosystems and sophisticated healthcare infrastructures. The ongoing biotechnology innovations with continuous improvement in qPCR software, reagents, and equipment are further driving market growth in the country.

How is the market for Real-time PCR qPCR Systems Shaping Up in Japan?

“Market Players Benefitting from Emphasis on Advanced Diagnostics and Precision Medicines”

Attribute	Japan
Market Value (2024E)	US$ 228 Million
Growth Rate (2024 to 2034)	8.2% CAGR
Projected Value (2034F)	US$ 504 Million

In Japan, sales of real-time PCR qPCR are increasing at a significant pace due to a well-established healthcare system with a strong emphasis on advanced diagnostics and precision medicines. Also, Japan is home to many leading biotechnology and pharmaceutical companies that investing in research & development, which driving the adoption of real-time PCR qPCR technologies in drug discovery, development, and clinical trials. Other than these factors, stringent regulatory standards and a culture of quality assurance in Japan ensure confidence in qPCR-based diagnostic tests, which is a key real-time PCR qPCR market trend.

Category-wise Insights

Based on application, the market is segmented into clinical, research, and forensic. The research segment is set to hold a significant market share of 59.1% in 2024 due to its crucial role in investigating gene expression, genetic diversity, and infectious illnesses, making it a valuable resource for researchers.

What is Driving Widespread Adoption of Reagents & Assays?

“Need for Real-Time PCR qPCR Systems in Crime Scene Investigations and Genetic Profiling”

Attribute	Reagents and Assays
Segment Value (2024E)	US$ 1.8 Billion
Growth Rate (2024 to 2034)	8.7% CAGR
Projected Value (2034F)	US$ 4.17 Billion

By product type, the market is segmented into real-time PCR (qPCR) systems, reagents & assays, and real-time PCR (qPCR) consumables. Rising sales of reagents and assays are driven by the increasing demand for these products in research, diagnostic, and forensic applications. The growing prevalence of infectious diseases, genetic disorders, and cancer is leading to an increase in the use of real-time PCR qPCR technology for accurate and sensitive detection of nucleic acids.

The versatility, reliability, and efficiency of real-time PCR qPCR technology are making them a preferred choice for nucleic acid quantification and detection, driving the demand for reagents and assays in the market.

Why Do Researchers in Academic Institutions Prefer Real-Time PCR qPCR?

“Real-Time PCR qPCR Offers Reproducible Results and Long-term Cost Savings”

Attribute	Academic & Research Institutes
Segment Value (2024E)	US$ 1.05 Billion
Growth Rate (2024 to 2034)	8.4% CAGR
Projected Value (2034F)	US$ 2.36 Billion

Real-time PCR qPCR product sales are growing in academic & research institutes as demand for these technologies is increasing in various scientific applications. The precision, sensitivity, and efficiency of real-time PCR qPCR systems make them an important tool for nucleic acid analysis, gene expression investigations, and other research projects.

Constant advancements in real-time PCR technology, as well as the availability of a diverse variety of particular reagents and assays, are accelerating its adoption in academic & research fields. As a result, many researchers now prefer real-time PCR qPCR.

Competitive Landscape

Key players in the real-time PCR qPCR market are focusing on enhancing their profits by launching and developing innovative real-time PCR qPCR tools and reagents and the expansion of their product lines.

• In April 2024, Bio-Rad Laboratories, Inc., a global leader in life sciences research and clinical diagnostics, introduced its first ultrasensitive multiplexed digital PCR test, the ddPLEX ESR1 Mutation Detection Kit.
• In December 2023, the biotechnology business Anitoa Systems introduced the real-time polymerase chain reaction (qPCR) modular system, Anitoa MAx16, which is suitable for automation.
• In October 2021, Bio-Rad Laboratories, Inc. developed the CFX Opus 96 Dx System. For in-vitro diagnostic testing, the novel gadget was designed to offer real-time PCR detection.
• In March 2021, the QuantStudio 5 Dx Real-Time PCR System was introduced by Thermo Fisher. The solutions were meant to be used by assay producers and clinical laboratories to carry out new tests and enhance molecular diagnostics processes.
• In October 2020, the National Institutes of Health (NIH) awarded Phase 2 funding to Visby Medical (the United States), an infectious disease diagnostic business, as part of its Rapid Acceleration of Diagnostics (RADx) project.

Fact.MR provides detailed information about the price points of leading manufacturers of real-time PCR qPCR systems positioned across the world, sales growth, production capacity, and speculative technological expansion in this new market report.

Segmentation of Real-Time PCR qPCR Market Research

• By Product Type :

  • Real-Time PCR qPCR Systems
  • Reagents & Assays
  • Real-Time PCR qPCR Consumables
    • PCR Primers, Assays, and Arrays
    • PCR Plates, Seals, & Tubes

• By Application :

  • Clinical
  • Research
  • Forensic

• By End User :

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Animal Health
  • Food & Agriculture Industries

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa